211 related articles for article (PubMed ID: 14507756)
1. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.
Prajna NV; John RK; Nirmalan PK; Lalitha P; Srinivasan M
Br J Ophthalmol; 2003 Oct; 87(10):1235-7. PubMed ID: 14507756
[TBL] [Abstract][Full Text] [Related]
2. Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis.
Prajna NV; Nirmalan PK; Mahalakshmi R; Lalitha P; Srinivasan M
Cornea; 2004 Nov; 23(8):793-6. PubMed ID: 15502480
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh.
Rahman MR; Johnson GJ; Husain R; Howlader SA; Minassian DC
Br J Ophthalmol; 1998 Aug; 82(8):919-25. PubMed ID: 9828778
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
5. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
[TBL] [Abstract][Full Text] [Related]
6. Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial.
Rajaraman R; Bhat P; Vaidee V; Maskibail S; Raghavan A; Sivasubramaniam S; Namperumalsamy VP
Asia Pac J Ophthalmol (Phila); 2015; 4(3):146-50. PubMed ID: 26065500
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
Sharma N; Singhal D; Maharana PK; Sinha R; Agarwal T; Upadhyay AD; Velpandian T; Satpathy G; Titiyal JS
Cornea; 2017 Dec; 36(12):1521-1527. PubMed ID: 28902012
[TBL] [Abstract][Full Text] [Related]
8. Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.
Gong H; Gong X
Eye Sci; 2013 Jun; 28(2):84-7. PubMed ID: 24396961
[TBL] [Abstract][Full Text] [Related]
9. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis.
Kalavathy CM; Parmar P; Kaliamurthy J; Philip VR; Ramalingam MD; Jesudasan CA; Thomas PA
Cornea; 2005 May; 24(4):449-52. PubMed ID: 15829804
[TBL] [Abstract][Full Text] [Related]
10. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
Prajna NV; Radhakrishnan N; Lalitha P; Austin A; Ray KJ; Keenan JD; Porco TC; Lietman TM; Rose-Nussbaumer J
Ophthalmology; 2020 Feb; 127(2):159-166. PubMed ID: 31619359
[TBL] [Abstract][Full Text] [Related]
11. Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.
Sharma N; Sahay P; Maharana PK; Singhal D; Saluja G; Bandivadekar P; Chako J; Agarwal T; Sinha R; Titiyal JS; Satpathy G; Velpandian T
Cornea; 2019 Feb; 38(2):141-145. PubMed ID: 30334872
[TBL] [Abstract][Full Text] [Related]
12. Natamycin and voriconazole in fungal keratitis.
Das M; Murthy SI; Dikshit S; Rathi V
Arch Ophthalmol; 2011 Jun; 129(6):814; author reply 814-5. PubMed ID: 21670358
[No Abstract] [Full Text] [Related]
13. Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates.
Pradhan L; Sharma S; Nalamada S; Sahu SK; Das S; Garg P
Indian J Ophthalmol; 2011; 59(6):512-4. PubMed ID: 22011503
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
15. Natamycin versus voriconazole for fungal keratitis.
Retamal J; Ordenes-Cavieres G; Grau-Diez A
Medwave; 2018 Dec; 18(8):e7388. PubMed ID: 30562337
[TBL] [Abstract][Full Text] [Related]
16. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin.
Malecha MA
Cornea; 2004 Mar; 23(2):201-3. PubMed ID: 15075891
[TBL] [Abstract][Full Text] [Related]
17. Medical interventions for fungal keratitis.
Florcruz NV; Peczon I
Cochrane Database Syst Rev; 2008 Jan; (1):CD004241. PubMed ID: 18254043
[TBL] [Abstract][Full Text] [Related]
18. [Fungal keratitis--diagnostic and therapeutic approach].
Niţulescu C
Oftalmologia; 2006; 50(4):33-8. PubMed ID: 17345800
[TBL] [Abstract][Full Text] [Related]
19. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
